These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 23107085)
21. Treatment options and recommendations to reduce preterm births in women with short cervix. Slager J; Lynne S J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244 [TBL] [Abstract][Full Text] [Related]
22. Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011. Sibai BM; Istwan NB; Palmer B; Stanziano GJ Am J Perinatol; 2012 Sep; 29(8):635-42. PubMed ID: 22576126 [TBL] [Abstract][Full Text] [Related]
23. Spontaneous Preterm Birth in Multiples. Biggio JR; Anderson S Clin Obstet Gynecol; 2015 Sep; 58(3):654-67. PubMed ID: 26083129 [TBL] [Abstract][Full Text] [Related]
24. [Prevention of preterm delivery with gestagens]. Schindler AE Z Geburtshilfe Neonatol; 2004 Oct; 208(5):165-9. PubMed ID: 15508049 [TBL] [Abstract][Full Text] [Related]
25. Progesterone inhibits basal and TNF-alpha-induced apoptosis in fetal membranes: a novel mechanism to explain progesterone-mediated prevention of preterm birth. Luo G; Abrahams VM; Tadesse S; Funai EF; Hodgson EJ; Gao J; Norwitz ER Reprod Sci; 2010 Jun; 17(6):532-9. PubMed ID: 20360593 [TBL] [Abstract][Full Text] [Related]
26. The case for universal cervical length screening to prevent preterm birth: is it strong enough to change practice in Canada? Hutcheon JA; Amanda Skoll M; Eastabrook GD; Lim KI; J Obstet Gynaecol Can; 2012 Dec; 34(12):1184-1187. PubMed ID: 23231802 [No Abstract] [Full Text] [Related]
27. A randomized trial of micronized progesterone for the prevention of recurrent preterm birth. Glover MM; McKenna DS; Downing CM; Smith DB; Croom CS; Sonek JD Am J Perinatol; 2011 May; 28(5):377-81. PubMed ID: 21380990 [TBL] [Abstract][Full Text] [Related]
28. Use of progesterone to prevent preterm birth at a tertiary care center. Bailit JL; Berkowitz R; Thorp JM; Cleary K; Hartmann KE; Mercer BM J Reprod Med; 2007 Apr; 52(4):280-4. PubMed ID: 17506366 [TBL] [Abstract][Full Text] [Related]
29. Medical and Surgical Interventions Available Before a Periviable Birth. Chien EK; Gibson KS Clin Perinatol; 2017 Jun; 44(2):347-360. PubMed ID: 28477665 [TBL] [Abstract][Full Text] [Related]
30. Practice bulletin no. 130: prediction and prevention of preterm birth. Committee on Practice Bulletins—Obstetrics, The American College of Obstetricians and Gynecologists Obstet Gynecol; 2012 Oct; 120(4):964-73. PubMed ID: 22996126 [No Abstract] [Full Text] [Related]
31. Reducing Barriers to 17-Hydroxprogestrone Caproate (17P) Injections to Prevent Recurrent Preterm Birth in Mississippi. Bofill JA; Collier CH; Pearson M; Shwayder JM; Morrison JC J Miss State Med Assoc; 2016 Nov; 57(11):350-351. PubMed ID: 30281234 [No Abstract] [Full Text] [Related]
32. Optimal routes of administration, vehicles and timing of progesterone treatment for inhibition of delivery during pregnancy. Fang D; Moreno M; Garfield RE; Kuon R; Xia H Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():164-168. PubMed ID: 28777967 [TBL] [Abstract][Full Text] [Related]
33. Prevention of periviable birth: bed rest, tocolysis, progesterone, and cerclage. Chien EK Semin Perinatol; 2013 Dec; 37(6):404-9. PubMed ID: 24290396 [TBL] [Abstract][Full Text] [Related]
34. A survey of clinician and patient attitudes towards the use of progesterone for women at risk of preterm birth. Dodd JM; Ashwood P; Flenady V; Jenkins-Manning S; Cincotta R; Crowther CA Aust N Z J Obstet Gynaecol; 2007 Apr; 47(2):106-9. PubMed ID: 17355298 [TBL] [Abstract][Full Text] [Related]
35. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial. Martinez de Tejada B; Karolinski A; Ocampo MC; Laterra C; Hösli I; Fernández D; Surbek D; Huespe M; Drack G; Bunader A; Rouillier S; López de Degani G; Seidenstein E; Prentl E; Antón J; Krähenmann F; Nowacki D; Poncelas M; Nassif JC; Papera R; Tuma C; Espoile R; Tiberio O; Breccia G; Messina A; Peker B; Schinner E; Mol BW; Kanterewicz L; Wainer V; Boulvain M; Othenin-Girard V; Bertolino MV; Irion O; BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926 [TBL] [Abstract][Full Text] [Related]
36. Population differences and the effect of vaginal progesterone on preterm birth in women with threatened preterm labor (.). Hermans FJ; Karolinski A; Othenin-Girard V; Bertolino MV; Schuit E; Salgado P; Hösli I; Irion O; Laterra C; Mol BW; Martinez de Tejada B J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3223-8. PubMed ID: 26586448 [TBL] [Abstract][Full Text] [Related]
37. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety. O'Brien JM; Lewis DF Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340 [TBL] [Abstract][Full Text] [Related]
38. Progesterone in normal and pathological pregnancy. Di Renzo GC; Giardina I; Clerici G; Brillo E; Gerli S Horm Mol Biol Clin Investig; 2016 Jul; 27(1):35-48. PubMed ID: 27662646 [TBL] [Abstract][Full Text] [Related]
39. Obstetric management of moderate and late preterm labour. McParland PC Semin Fetal Neonatal Med; 2012 Jun; 17(3):138-42. PubMed ID: 22410256 [TBL] [Abstract][Full Text] [Related]
40. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella Am J Obstet Gynecol; 2012 May; 206(5):376-86. PubMed ID: 22542113 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]